Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Regional conduction velocities determined by noninvasive mapping are associated with arrhythmia-free survival after atrial fibrillation ablation

  • Invers-Rubio, Eric
  • Hernández-Romero, Ismael
  • Reventós-Presmanes, Jana
  • Ferró, Elisenda
  • Guichard, Jean Baptiste
  • Regany-Closa, Mariona
  • Pellicer-Sendra, Berta
  • Borrás, Roger
  • Tolosana, José María
  • Prat-Gonzalez, Susanna
  • Porta-Sanchez, Andreu
  • Arbelo, Elena
  • Guasch, Eduard
  • Sitges, Marta
  • Brugada, Josep
  • Roca-Luque, Ivo
  • Lluís Mont
  • TF Althoff
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Andreu M. Climent|||0000-0002-7260-8811
[EN] BACKGROUND Atrial arrhythmogenic substrate is a key determinant of atrial fibrillation (AF) recurrence after pulmonary vein isolation (PVI), and reduced conduction velocities have been linked to adverse outcome. However, a noninvasive method to assess such electrophysiologic substrate is not available to date. OBJECTIVE This study aimed to noninvasively assess regional conduction velocities and their association with arrhythmia-free survival after PVI. METHODS A consecutive 52 patients scheduled for AF ablation (PVI only) and 19 healthy controls were prospectively included and received electrocardiographic imaging (ECGi) to noninvasively determine regional atrial conduction velocities in sinus rhythm. A novel ECGi technology obviating the need of additional computed tomography or cardiac magnetic resonance imaging was applied and validated by invasive mapping. RESULTS Mean ECGi-determined atrial conduction velocities were significantly lower in AF patients than in healthy controls (1.45 6 0.15 m/s vs 1.64 6 0.15 m/s; P < .0001). Differences were particularly pronounced in a regional analysis considering only the segment with the lowest average conduction velocity in each patient (0.8 6 0.22 m/s vs 1.08 6 0.26 m/s; P < .0001). This average conduction velocity of the ¿slowest¿ segment was independently associated with arrhythmia recurrence and better discriminated between PVI responders and nonresponders than previously proposed predictors, including left atrial size and late gadolinium enhancement (magnetic resonance imaging). Patients without slow-conduction areas (mean conduction velocity <0.78 m/s) showed significantly higher 12-month arrhythmia-free survival than those with 1 or more slow-conduction areas (88.9% vs 48.0%; P 5 .002). CONCLUSION This is the first study to investigate regional atrial conduction velocities noninvasively. The absence of ECGi-determined slow-conduction areas well discriminates PVI responders from nonresponders. Such noninvasive assessment of electrical arrhythmogenic substrate may guide treatment strategies and be a step toward personalized AF therapy., This work is supported in part by grants from the European Union s Horizon Research and Innovation Programme under the Marie Sk1odowska-Curie Grant Agreement (860974; to M.S.G.); Instituto de Salud Carlos III, Spanish Government, Madrid, Spain (FIS_PI16/00435 FIS_CIBER16; to L.M.); Ministerio de Ciencia e Innovación (supported by FEDER Fondo Europeo de Desarrollo Regional PI17/01106, PEJ2018-003617, and RYC2018-024346-I; to A.M.C.), EIT Health (SAVE-COR Activity code 220385, EIT Health is supported by EIT, a body of the European Union), Generalitat Valenciana Conselleria d Educació, Investigació, Cultura i Esport (ACIF/2020/265; to A.C.), and Spanish Agencia Estatal de Investigación (AEI), part of the Ministerio de Ciencia e Innovación, reference PID2020-119364RB-I00 (to A.C.).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A cyclical fast iterative method for simulating reentries in cardiac electrophysiology using an eikonal-based model

  • Barrios Espinosa, Cristian
  • Appel, Stephanie
  • Becker, Silvia
  • Krauss, Jonathan
  • Martinez Díaz, Patricia
  • Unger, Laura
  • Houillon, Marie
  • Loewe, Axel
  • Sánchez-Arciniegas, Jorge Patricio
[EN] Computer models for simulating cardiac electrophysiology are valuable tools for research and clinical applications. Traditional reaction¿difusion (RD) models used for these purposes are computationally expensive. While eikonal models ofer a faster alternative, they are not well-suited to study cardiac arrhythmias driven by reentrant activity. The present work extends the difusion¿reaction eikonal alternant model (DREAM), incorporating conduction velocity (CV) restitution for simulating complex cardiac arrhythmias. The DREAM modifes the fast iterative method to model cyclical behavior, dynamic boundary conditions, and frequency-dependent anisotropic CV. Additionally, the model alternates with an approximated RD model, using a detailed ionic model for the reaction term and a triple-Gaussian to approximate the difusion term. The DREAM and monodomain models were compared, simulating reentries in 2D manifolds with diferent resolutions. The DREAM produced similar results across all resolutions, while experiments with the monodomain model failed at lower resolutions. CV restitution curves obtained using the DREAM closely approximated those produced by the monodomain simulations. Reentry in 2D sheets yielded similar results in vulnerable window and mean reentry duration for low CV in both models. In the left atrium, most inducing points identifed by the DREAM were also present in the high-resolution monodomain model. DREAM¿s reentry simulations on meshes with an average edge length of 1600 ¿m were 87x faster than monodomain simulations at 200 ¿m. This work establishes the mathematical foundation for using the accelerated DREAM simulation method for cardiac electrophysiology. Cardiac research applications are enabled by a publicly available implementation in the openCARP simulator, This work was supported from the European Union s Horizon research and Innovation programme under the Marie Sklodowska-Curie grant agreement No. 860974, by the Leibniz ScienceCampus Digital Transformation of Research with funds from the programme Strategic Networking in the Leibniz Association , the European High-Performance Computing Joint Undertaking EuroHPC under grant agreement No 955495 (MICROCARD) co-funded by the Horizon 2020 programme of the European Union (EU) and the German Federal Ministry of Education and Research (BMBF), by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID 258734477-SFB 1173 and LO 2093/6-1 (SPP 2311) and-Project-ID 394433254 (LU 2294/1-1, DO 637/23-1, WA 4259/1-1), and by the MCIN\AEI and the European Union NextGenerationEU\ RTR under grant PLEC2021-007614.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Atrial fibrosis identification with unipolar electrogram eigenvalue distribution analysis in multi-electrode arrays

  • Riccio, Jennifer
  • Alcaine, Alejandro
  • Rocher, Sara
  • Martínez-Mateu, Laura
  • Invers-Rubio, Eric
  • Martínez, Juan Pablo
  • Laguna, Pablo
  • Saiz Rodríguez, Francisco Javier|||0000-0002-9850-0825
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] Atrial fibrosis plays a key role in the initiation and progression of atrial fibrillation (AF). Atrial fibrosis is typically identified by a peak-to-peak amplitude of bipolar electrograms (b-EGMs) lower than 0.5 mV, which may be considered as ablation targets. Nevertheless, this approach disregards signal spatiotemporal information and b-EGM sensitivity to catheter orientation. To overcome these limitations, we propose the dominant-to-remaining eigenvalue dominance ratio (EIGDR) of unipolar electrograms (u-EGMs) within neighbor electrode cliques as a waveform dispersion measure, hypothesizing that it is correlated with the presence of fibrosis. A simulated 2D tissue with a fibrosis patch was used for validation. We computed EIGDR maps from both original and time-aligned u-EGMs, denoted as R and R-A, respectively, also mapping the gain in eigenvalue concentration obtained by the alignment, Delta R-A. The performance of each map in detecting fibrosis was evaluated in scenarios including noise and variable electrode-tissue distance. Best results were achieved by R-A, reaching 94% detection accuracy, versus the 86% of b-EGMs voltage maps. The proposed strategy was also tested in real u-EGMs from fibrotic and non- fibrotic areas over 3D electroanatomical maps, supporting the ability of the EIGDRs as fibrosis markers, encouraging further studies to confirm their translation to clinical settings., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This work was supported by European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Sklodowska-Curie Grant Agreements No. 766082 and No. 860974, by projects PID2019-105674RBI00, PID2019-104881RB-I00 (MICINN) and Aragon Government (Reference Group Biomedical Signal Interpretation and Computational Simulation (BSICoS) T39-20R) cofunded by FEDER 20142020 "Building Europe from Aragon", by fellowship ACIF/2018/174 and Grant PROMETEO/2020/043, both from Direccion General de Politica Cientifica de la Generalitat Valenciana, and by DENIS Project (Volunteer Computer platform) supported through CoMBA 2021-2022 internal projects call from Universidad San Jorge.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Non-invasive estimation of atrial fibrillation driver position using long-short term memory neural networks and body surface potentials

  • Gutiérrez-Fernández-Calvillo, Miriam
  • Cámara-Vázquez, Miguel Ángel
  • Hernández-Romero, Ismael
  • Climent, Andreu M.
  • Barquero-Pérez, Óscar
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Fambuena-Santos, Carlos
[EN] Background and Objective: Atrial Fibrillation (AF) is a supraventricular tachyarrhythmia that can lead to thromboembolism, hearlt failure, ischemic stroke, and a decreased quality of life. Characterizing the locations where the mechanisms of AF are initialized and maintained is key to accomplishing an effective ablation of the targets, hence restoring sinus rhythm. Many methods have been investigated to locate such targets in a non-invasive way, such as Electrocardiographic Imaging, which enables an on -invasive and panoramic characterization of cardiac electrical activity using recording Body Surface Potentials (BSP) and a torso model of the patient. Nonetheless, this technique entails some major issues stemming from solving the inverse problem, which is known to be severely ill -posed. In this context, many machine learning and deep learning approaches aim to tackle the characterization and classification of AF targets to improve AF diagnosis and treatment. Methods: In this work, we propose a method to locate AF drivers as a supervised classification problem. We employed a hybrid form of the convolutional -recurrent network which enables feature extraction and sequential data modeling utilizing labeled realistic computerized AF models. Thus, we used 16 AF electrograms, 1 atrium, and 10 torso geometries to compute the forward problem. Previously, the AF models were labeled by assigning each sample of the signals a region from the atria from 0 (no driver) to 7, according to the spatial location of the AF driver. The resulting 160 BSP signals, which resemble a 64 -lead vest recording, are preprocessed and then introduced into the network following a 4 -fold cross -validation in batches of 50 samples. Results: The results show a mean accuracy of 74.75% among the 4 folds, with a better performance in detecting sinus rhythm, and drivers near the left superior pulmonary vein (R1), and right superior pulmonary vein (R3) whose mean sensitivity bounds around 84%-87%. Significantly good results are obtained in mean sensitivity (87%) and specificity (83%) in R1. Conclusions: Good results in R1 are highly convenient since AF drivers are commonly found in this area: the left atrial appendage, as suggested in some previous studies. These promising results indicate that using CNN-LSTM networks could lead to new strategies exploiting temporal correlations to address this challenge effectively., This work has been partially supported by: Ministerio de Ciencia e Innovacion (PID2019-105032GB-I00, PID2022-136887NB-I00) , Rey Juan Carlos University (2023/00004/006-F918) , Instituto de Salud Carlos III and Ministerio de Ciencia, Innovacion y Universidades (supported by FEDER Fondo Europeo de Desarrollo Regional PI17/01106 and Consejeria de Ciencia, Universidades e Innovacion of the Comunidad de Madrid through the program RIS3 (S-2020/L2-622) , EIT Health Activity code 19600 and the European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 860974.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

AF driver detection in pulmonary vein area by electropcardiographic imaging: Relation with a favorable outcome of pulmonary vein isolation

  • Fambuena-Santos, Carlos
  • Andreu M. Climent|||0000-0002-7260-8811
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Hernández-Romero, Ismael
  • Molero-Alabau, Rubén
  • Atienza, Felipe
[EN] Pulmonary vein isolation (PVI) is the most successful treatment for atrial fibrillation (AF) nowadays. However, not all AF patients benefit from PVI. In this study, we evaluate the use of ECGI to identify reentries and relate rotor density in the pulmonary vein (PV) area as an indicator of PVI outcome. Rotor maps were computed in a set of 29 AF patients using a new rotor detection algorithm. The relationship between the distribution of reentrant activity and the clinical outcome after PVI was studied. The number of rotors and proportion of PSs in different atrial regions were computed and compared retrospectively in two groups of patients: patients that remained in sinus rhythm 6 months after PVI and patients with arrhythmia recurrence. The total number of rotors obtained was higher in patients returning to arrhythmia after the ablation (4.31 ± 2.77 vs. 3.58 ± 2.67%, p = 0.018). However, a significantly higher concentration of PSs in the pulmonary veins was found in patients that remained in sinus rhythm (10.20 ± 12.40% vs. 5.19 ± 9.13%, p = 0.011) 6 months after PVI. The results obtained show a direct relationship between the expected AF mechanism and the electrophysiological parameters provided by ECGI, suggesting that this technology offers relevant information to predict the clinical outcome after PVI in AF patients., This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 860974, PersonalizeAF, Ministerio de Ciencia e Innovacion (supported by FEDER Fondo Europeo de Desarrollo Regional PI17/01106, PEJ2018-003617, and RYC2018-024346-I), EIT Health (SAVE-COR Activity code 220385, EIT Health is supported by EIT, a body of the European Union), Generalitat Valenciana Conselleria d'Educacio, Investigacio, Cultura i Esport (ACIF/2020/265) and Spanish Agencia Estatal de Investigacion (AEI), part of the Ministerio de Ciencia e Innovacion, reference PID2020-119364RB-I00. *This publication reflects only the author's view and that the Agency is not responsible for any use that may be made of the information it contains.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Comparison of the Impact of Pharmacological Treatments on Cardioversion, Rate Control, and Mortality in Data-Driven Atrial Fibrillation Phenotypes in Critical Care

  • Lacki, Alexander
  • Martinez-Millana, Antonio|||0000-0003-1056-5067
[EN] Critical care physicians are commonly faced with patients exhibiting atrial fibrillation (AF), a cardiac arrhythmia with multifaceted origins. Recent investigations shed light on the heterogeneity among AF patients by uncovering unique AF phenotypes, characterized by differing treatment strategies and clinical outcomes. In this retrospective study encompassing 9401 AF patients in an intensive care cohort, we sought to identify differences in average treatment effects (ATEs) across different patient groups. We extract data from the MIMIC-III database, use hierarchical agglomerative clustering to identify patients' phenotypes, and assign them to treatment groups based on their initial drug administration during AF episodes. The treatment options examined included beta blockers (BBs), potassium channel blockers (PCBs), calcium channel blockers (CCBs), and magnesium sulfate (MgS). Utilizing multiple imputation and inverse probability of treatment weighting, we estimate ATEs related to rhythm control, rate control, and mortality, approximated as hourly and daily rates (%/h, %/d). Our analysis unveiled four distinctive AF phenotypes: (1) postoperative hypertensive, (2) non-cardiovascular mutlimorbid, (3) cardiovascular multimorbid, and (4) valvulopathy atrial dilation. PCBs showed the highest cardioversion rates across phenotypes, ranging from 11.6%/h (9.35-13.3) to 7.69%/h (5.80-9.22). While CCBs demonstrated the highest effectiveness in controlling ventricular rates within the overall patient cohort, PCBs and MgS outperformed them in specific phenotypes. PCBs exhibited the most favorable mortality outcomes overall, except for the non-cardiovascular multimorbid cluster, where BBs displayed a lower mortality rate of 1.33%/d [1.04-1.93] compared to PCBs' 1.68%/d [1.10-2.24]. The results of this study underscore the significant diversity in ATEs among individuals with AF and suggest that phenotype-based classification could be a valuable tool for physicians, providing personalized insights to inform clinical decision making., This project has received funding from the European Union s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860974. This publication reflects only the authors view, and the funding agencies are not responsible for any use that may be made of the information it contains.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Standardized 2D atrial mapping and its clinical applications

  • Wang, Tiantian
  • Karel, Joël
  • Invers-Rubio, Eric
  • Hernández-Romero, Ismael
  • Peeters, Ralf
  • Bonizzi, Pietro
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] The visualization and comparison of electrophysiological information in the atrium among different patients could be facilitated by a standardized 2D atrial mapping. However, due to the complexity of the atrial anatomy, unfolding the 3D geometry into a 2D atrial mapping is challenging. In this study, we aim to develop a standardized approach to achieve a 2D atrial mapping that connects the left and right atria, while maintaining fixed positions and sizes of atrial segments across individuals. Atrial segmentation is a prerequisite for the process. Segmentation includes 19 different segments with 12 segments from the left atrium, 5 segments from the right atrium, and two segments for the atrial septum. To ensure consistent and physiologically meaningful segment connections, an automated procedure is applied to open up the atrial surfaces and project the 3D information into 2D. The corresponding 2D atrial mapping can then be utilized to visualize different electrophysiological information of a patient, such as activation time patterns or phase maps. This can in turn provide useful information for guiding catheter ablation. The proposed standardized 2D maps can also be used to compare more easily structural information like fibrosis distribution with rotor presence and location. We show several examples of visualization of different electrophysiological properties for both healthy subjects and patients affected by atrial fibrillation. These examples show that the proposed maps provide an easy way to visualize and interpret intra-subject information and perform inter-subject comparison, which may provide a reference framework for the analysis of the atrial fibrillation substrate before treatment, and during a catheter ablation procedure., This work has been supported in part by a grant from the European Union's Horizon Research and Innovation Programme under the Marie Sklodowska-Curie Grant Agreement (no 860974). Tiantian Wang is funded by the China Scholarship Council (CSC), grant number 201908210340. We would like to thank Shuhe Zhang for the fruitful discussions on the methods and algorithms.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value

  • Salinet, Joao
  • Molero-Alabau, Rubén
  • Schlindwein, Fernando S.
  • Karel, Joël
  • Rodrigo, Miguel
  • Rojo-Álvarez, José Luis
  • Berenfeld, Omer
  • Zenger, Brian
  • Vanheusden, Frederique
  • Siles Paredes, Jimena Gabriela
  • MacLeod, Rob
  • Atienza, Felipe
  • Cluitmans, Matthijs
  • Bonizzi, Pietro
  • Andreu M. Climent|||0000-0002-7260-8811
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] Electrocardiographic imaging (ECGI) is a technique to reconstruct non-invasively the electrical activity on the heart surface from body-surface potential recordings and geometric information of the torso and the heart. ECGI has shown scientific and clinical value when used to characterize and treat both atrial and ventricular arrhythmias. Regarding atrial fibrillation (AF), the characterization of the electrical propagation and the underlying substrate favoring AF is inherently more challenging than for ventricular arrhythmias, due to the progressive and heterogeneous nature of the disease and its manifestation, the small volume and wall thickness of the atria, and the relatively large role of microstructural abnormalities in AF. At the same time, ECGI has the advantage over other mapping technologies of allowing a global characterization of atrial electrical activity at every atrial beat and non-invasively. However, since ECGI is time-consuming and costly and the use of electrical mapping to guide AF ablation is still not fully established, the clinical value of ECGI for AF is still under assessment. Nonetheless, AF is known to be the manifestation of a complex interaction between electrical and structural abnormalities and therefore, true electro-anatomical-structural imaging may elucidate important key factors of AF development, progression, and treatment. Therefore, it is paramount to identify which clinical questions could be successfully addressed by ECGI when it comes to AF characterization and treatment, and which questions may be beyond its technical limitations. In this manuscript we review the questions that researchers have tried to address on the use of ECGI for AF characterization and treatment guidance (for example, localization of AF triggers and sustaining mechanisms), and we discuss the technological requirements and validation. We address experimental and clinical results, limitations, and future challenges for fruitful application of ECGI for AF understanding and management. We pay attention to existing techniques and clinical application, to computer models and (animal or human) experiments, to challenges of methodological and clinical validation. The overall objective of the study is to provide a consensus on valuable directions that ECGI research may take to provide future improvements in AF characterization and treatment guidance., JS was supported by Grants #2020/12841-3, #2020/13017-2, and #2018/25606-2, Sao Paulo Research Foundation (FAPESP). FS was supported by research grants from the Medical Research Council UK (MR/S037306/1), and from the British Heart Foundation (BHF Project Grant No. PG/18/33/33780). JR-A was supported by the projects (PID2019-106623RBC41) and meHeart (PID2019-104356RB-C42 and PID2019104356RB-C43) from the Spanish Government. JP was funded by Program of Alliances for Education and Training (Scholarship Brazil-PAEC OEA-GCUB-2017). RM, AC, and MG were supported by the Instituto de Salud Carlos III, and Ministerio de Ciencia, Innovacion y Universidades (supported by the FEDER Fondo Europeo de Desarrollo Regional PI17/01106 and RYC2018-024346B-750), EIT Health (Activity code 19600, EIT Health was supported by the EIT, a body of the European Union), received funding from the European Union's Horizon research and Innovation programme under the Marie Sklodowska-Curie grant agreement no. 860974 and the Generalitat Valenciana Grants (ACIF/2020/265). BZ and RM were supported by the NIH NHLBI Grant No. 1F30HL149327; NIH NIGMS Center for Integrative Biomedical Computing (www.sci.utah.edu/cibc), NIH NIGMS Grants P41GM103545 and R24 GM136986; and the Nora Eccles Treadwell Foundation for Cardiovascular Research. OB was supported in part by research grants from the National Institutes of Health (R01-HL118304 and R21-HL153694), Abbott, Medtronic, and CoreMap. MC was supported by a Veni Grant from the Netherlands Organization for Scientific Research (TTW 16772). FA was supported by the Instituto de Salud Carlos III (PI17/010559 and PI20/01618) and the Consorcio de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV), the Ministerio de Ciencia e Innovacion (cofound by FEDER: Fondo Europeo de Desarrollo Regional), EIT Health (AFFINE 19600, EIT Health was supported by EIT, a body of the European Union).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Enhancing premature ventricular contraction localization through electrocardiographic imaging and cardiac digital twins

  • Sánchez-Arciniegas, Jorge Patricio
  • Llorente-Lipe, Inés|||0009-0005-3386-0407
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Barrios Espinosa, Cristian
  • Loewe, Axel
  • Hernández-Romero, Ismael
  • Vicente, Jorge
  • Ros, Santiago
  • Atienza, Felipe
  • Carta-Bergaz, Alejandro
  • Climent, Andreu M.
[EN] Premature ventricular contractions (PVCs) represent a common and clinically significant cardiac arrhythmia, contributing to a spectrum of cardiovascular disorders. Accurate localization of the origin of PVCs is essential for devising targeted therapeutic strategies and refining our comprehension of ventricular arrhythmogenesis. Traditionally, the 12-lead ECG has been the go-to diagnostic tool for PVCs. However, individual anatomical differences and inter-patient electrophysiology variability limit its effectiveness. This study presents a new method that combines electrocardiographic imaging (ECGI) with the concept of cardiac digital twins (ECGIDT) to improve the accuracy of pinpointing the source of PVCs. By simulating a database of PVCs, we developed an ECGI-DT capable of estimating the origins of PVCs with much greater precision than possible previously. This study shows a notable improvement in identifying the initial site of PVC origin using ECGI-DT compared to ECGI alone: the average localization error dropped from 30.69 ± 23.71 mm with standard ECGI to 7.81 ± 3.82 mm using the ECGI-DT method. This marked reduction in error highlights the potential of ECGI-DT in revolutionizing PVC diagnosis and treatment. With its ability to provide more accurate and reliable data, ECGI-DT could improve the planning of catheter ablation treatments, a preferred intervention for managing PVCs that face challenges such as high costs and in some cases long procedure times., This work was supported by grants PLEC2021-007614 funded by MCIN, Spain&#8725;AEI&#8725;10.13039&#8725;501100011033 and by European Union NextGenerationEU&#8725;PRTR . This was supported by grant RYC2018-024346-I and by ESF Investing in your future, Spain . This project has received funding from the European Union s Horizon 2020 research and innovation programme under the Marie Sk&#322;odowska-Curie grant agreement No. 860974. This work was supported by the Leibniz ScienceCampus, Germany Digital Transformation of Research with funds from the programme Strategic Networking in the Leibniz Association . This research was supported by Deutsche Forschungsgemeinschaft, Germany (DFG, German Research Foundation) under grant LO 2093/9-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Non-invasive Estimation of Atrial Fibrillation Driver Position With Convolutional Neural Networks and Body Surface Potentials

  • Cámara-Vázquez, Miguel Ángel
  • Hernández-Romero, Ismael
  • Morgado-Reyes, Eduardo
  • Barquero-Pérez, Oscar
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
  • Andreu M. Climent|||0000-0002-7260-8811
[EN] Atrial fibrillation (AF) is characterized by complex and irregular propagation patterns, and AF onset locations and drivers responsible for its perpetuation are the main targets for ablation procedures. ECG imaging (ECGI) has been demonstrated as a promising tool to identify AF drivers and guide ablation procedures, being able to reconstruct the electrophysiological activity on the heart surface by using a non-invasive recording of body surface potentials (BSP). However, the inverse problem of ECGI is ill-posed, and it requires accurate mathematical modeling of both atria and torso, mainly from CT or MR images. Several deep learning-based methods have been proposed to detect AF, but most of the AF-based studies do not include the estimation of ablation targets. In this study, we propose to model the location of AF drivers from BSP as a supervised classification problem using convolutional neural networks (CNN). Accuracy in the test set ranged between 0.75 (SNR = 5 dB) and 0.93 (SNR = 20 dB upward) when assuming time independence, but it worsened to 0.52 or lower when dividing AF models into blocks. Therefore, CNN could be a robust method that could help to non-invasively identify target regions for ablation in AF by using body surface potential mapping, avoiding the use of ECGI., This work has been partially supported by: Ministerio de Ciencia e Innovacion (PID2019-105032GB-I00), Instituto de Salud Carlos III, and Ministerio de Ciencia, Innovacion y Universidades (supported by FEDER Fondo Europeo de Desarrollo Regional PI17/01106 and RYC2018-024346B-750), Consejeria de Ciencia, Universidades e Innovacion of the Comunidad de Madrid through the program RIS3 (S-2020/L2-622), EIT Health (Activity code 19600, EIT Health is supported by EIT, a body of the European Union) and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 860974.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Editorial: Atrial Fibrillation: Technology for Diagnosis, Monitoring, and Treatment

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Atrial fibrosis identification with unipolar electrogram eigenvalue distribution analysis in multi-electrode arrays

  • Riccio, Jennifer
  • Alcaine, Alejandro
  • Rocher, Sara
  • Martinez-Mateu, Laura
  • Saiz, Javier
  • Invers-Rubio, Eric
  • Guillem, Maria S.
  • Martínez, Juan Pablo
  • Laguna, Pablo
Atrial fbrosis plays a key role in the initiation and progression of atrial fbrillation (AF). Atrial fbrosis is typically identifed by a peak-to-peak amplitude of bipolar electrograms (b-EGMs) lower than 0.5 mV, which may be considered as ablation targets. Nevertheless, this approach disregards signal spatiotemporal information and b-EGM sensitivity to catheter orientation. To overcome these limitations, we propose the dominant-to-remaining eigenvalue dominance ratio (EIGDR) of unipolar electrograms (u-EGMs) within neighbor electrode cliques as a waveform dispersion measure, hypothesizing that it is correlated with the presence of fbrosis. A simulated 2D tissue with a fbrosis patch was used for validation. We computed EIGDR maps from both original and time-aligned u-EGMs, denoted as R and RA, respectively, also mapping the gain in eigenvalue concentration obtained by the alignment, ΔRA. The performance of each map in detecting fbrosis was evaluated in scenarios including noise and variable electrode-tissue distance. Best results were achieved by RA, reaching 94% detection accuracy, versus the 86% of b-EGMs voltage maps. The proposed strategy was also tested in real u-EGMs from fbrotic and non-fbrotic areas over 3D electroanatomical maps, supporting the ability of the EIGDRs as fbrosis markers, encouraging further studies to confrm their translation to clinical settings.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease

  • Young, W. J.
  • Haessler, J.
  • Benjamins, J. W.
  • Repetto, L.
  • Yao, J.
  • Isaacs, A.
  • Harper, A. R.
  • Ramirez, J.
  • Garnier, S.
  • van Duijvenboden, S.
  • Baldassari, A. R.
  • Pina Concas, M.
  • Duong, T.
  • Foco, L.
  • Isaksen, J. L.
  • Mei, H.
  • Noordam, R.
  • Nursyifa, C.
  • Richmond, A.
  • Santolalla, M. L.
  • Sitlani, C. M.
  • Soroush, N.
  • Thériault, S.
  • Trompet, S.
  • Aeschbacher, S.
  • Ahmadizar, F.
  • Alonso, A.
  • Brody, J. A.
  • Campbell, A.
  • Correa, A.
  • Darbar, D.
  • De Luca, A.
  • Deleuze, J. F.
  • Ellervik, C.
  • Fuchsberger, C.
  • Goel, A.
  • Grace, C.
  • Guo, X.
  • Hansen, T.
  • Heckbert, S. R.
  • Jackson, R. D.
  • Kors, J. A.
  • Lima-Costa, M. F.
  • Linneberg, A.
  • Macfarlane, P. W.
  • Morrison, A. C.
  • Navarro, P.
  • Porteous, D. J.
  • Pramstaller, P. P.
  • Reiner, A. P.
  • Risch, L.
  • Schotten, U.
  • Shen, X.
  • Sinagra, G.
  • Soliman, E. Z.
  • Stoll, M.
  • Tarazona-Santos, E.
  • Tinker, A.
  • Trajanoska, K.
  • Villard, E.
  • Warren, H. R.
  • Whitsel, E. A.
  • Wiggins, K. L.
  • Arking, D. E.
  • Avery, C. L.
  • Conen, D.
  • Girotto, G.
  • Grarup, N.
  • Hayward, C.
  • Jukema, J. W.
  • Mook-Kanamori, D. O.
  • Olesen, M. S.
  • Padmanabhan, S.
  • Psaty, B. M.
  • Pattaro, C.
  • Ribeiro, A. L. P.
  • Rotter, J. I.
  • Stricker, B. H.
  • van der Harst, P.
  • van Duijn, C. M.
  • Verweij, N.
  • Wilson, J. G.
  • Orini, M.
  • Charron, P.
  • Watkins, H.
  • Kooperberg, C.
  • Lin, H. J.
  • Wilson, J. F.
  • Kanters, J. K.
  • Sotoodehnia, N.
  • Mifsud, B.
  • Lambiase, P. D.
  • Tereshchenko, L. G.
  • Munroe, P. B.
The 3-dimensional spatial and 2-dimensional frontal QRS-T angles are measures derived from the vectorcardiogram. They are independent risk predictors for arrhythmia, but the underlying biology is unknown. Using multi-ancestry genome-wide association studies we identify 61 (58 previously unreported) loci for the spatial QRS-T angle (N = 118,780) and 11 for the frontal QRS-T angle (N = 159,715). Seven out of the 61 spatial QRS-T angle loci have not been reported for other electrocardiographic measures. Enrichments are observed in pathways related to cardiac and vascular development, muscle contraction, and hypertrophy. Pairwise genome-wide association studies with classical ECG traits identify shared genetic influences with PR interval and QRS duration. Phenome-wide scanning indicate associations with atrial fibrillation, atrioventricular block and arterial embolism and genetically determined QRS-T angle measures are associated with fascicular and bundle branch block (and also atrioventricular block for the frontal QRS-T angle). We identify potential biology involved in the QRS-T angle and their genetic relationships with cardiovascular traits and diseases, may inform future research and risk prediction.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Editorial: Atrial Fibrillation: Technologies for Investigation, Monitoring and Treatment, Volume II